EMA Application withdrawn: Ramelteon — Takeda Global Research Development Centre (Europe) Ltd.

View source ↗

Summary

The EMA indicates the ramelteon application by Takeda was withdrawn (Decision date 31/12/2009) for sleep initiation and maintenance disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep Initiation Disorders
• Sleep Maintenance Disorders

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Status: Application withdrawn. Therapeutic area: Sleep Initiation and Maintenance Disorders. MAH: Takeda Global Research Development Centre (Europe) Ltd.. Decision date: 31/12/2009